Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Orthopedic Surgery, Capio Sankt Göran Hospital, Stockholm, Sweden.
Acta Orthop. 2021 Oct;92(5):507-512. doi: 10.1080/17453674.2021.1941627. Epub 2021 Jun 24.
Background and purpose - Emerging evidence from sham-controlled trials suggest that surgical treatment entails substantial non-specific treatment effects in addition to specific surgical effects. Yet, information on surgeons' actual behaviors and beliefs regarding non-specific treatment and placebo effects is scarce. We determined surgeons' clinical behaviors and attitudes regarding placebo effects.Methods - A national online survey was developed in collaboration with surgeons and administered via an electronic link.Results - All surgical clinics in Sweden were approached and 22% of surgeons participated (n = 105). Surgeons believed it was important for them to interact and build rapport with patients before surgery rather than perform surgery on colleagues' patients (90%). They endorsed the importance of non-specific treatment effects in surgery generally (90%) and reported that they actively harness non-specific treatment effects (97%), including conveying confidence and calm (87%), building a positive interaction (75%), and making eye contact (72%). In communication regarding the likely outcomes of surgery, surgeons emphasized accurate scientific information of benefits/risks (90%) and complete honesty (63%). A majority felt that the improvement after some currently performed surgical procedures might be entirely explained by placebo effects (78%). Surgeons saw benefits with sham-controlled surgery trials, nevertheless, they were reluctant to refer patients to sham controlled trials (46%).Interpretation - Surgeons believe that their words and behaviors are important components of their professional competence. Surgeons saw the patient-physician relationship, transparency, and honesty as critical. Understanding the non-specific components of surgery has the potential to improve the way surgical treatment is delivered and lead to better patient outcomes.
背景与目的——来自假手术对照试验的新证据表明,除了特定的手术效果外,手术治疗还会产生大量的非特异性治疗效果。然而,关于外科医生对非特异性治疗和安慰剂效应的实际行为和信念的信息却很少。我们旨在确定外科医生对安慰剂效应的临床行为和态度。
方法——与外科医生合作开发了一项全国性在线调查,并通过电子链接进行管理。
结果——所有瑞典的外科诊所都被联系到,有 22%的外科医生参与(n=105)。外科医生认为,在手术前与患者互动并建立融洽关系比为同事的患者做手术更为重要(90%)。他们普遍认为手术中非特异性治疗效果很重要,并报告说他们积极利用非特异性治疗效果(97%),包括表现出信心和冷静(87%)、建立积极的互动(75%)以及眼神交流(72%)。在讨论手术可能结果的沟通中,外科医生强调准确的受益/风险的科学信息(90%)和完全诚实(63%)。大多数人认为目前一些外科手术的改善可能完全可以用安慰剂效应来解释(78%)。外科医生认为假手术对照试验有其益处,但他们不愿意将患者转介到假手术对照试验中(46%)。
解释——外科医生认为他们的言语和行为是其专业能力的重要组成部分。外科医生认为医患关系、透明度和诚实至关重要。了解手术的非特异性成分有可能改善手术治疗的方式,并带来更好的患者结局。